Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Change in Receivables (2024 - 2025)

Historic Change in Receivables for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $1.7 million.

  • Kestra Medical Technologies' Change in Receivables rose 791.14% to $1.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $7.8 million, marking a year-over-year change of. This contributed to the annual value of $8.8 million for FY2025, which is 25136.11% up from last year.
  • According to the latest figures from Q4 2025, Kestra Medical Technologies' Change in Receivables is $1.7 million, which was up 791.14% from $1.8 million recorded in Q3 2025.
  • In the past 5 years, Kestra Medical Technologies' Change in Receivables registered a high of $2.9 million during Q3 2024, and its lowest value of $1.1 million during Q2 2024.